1 Market Overview

• 1.1 Product Overview and Scope
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Classification of Capillary Sequencing by Type
  • 1.3.1 Overview: Global Capillary Sequencing Market Size by Type: 2021 Versus 2025 Versus 2032
  • 1.3.2 Global Capillary Sequencing Consumption Value Market Share by Type in 2025
  • 1.3.3 Capillary Gel Electrophoresis (CGE)
  • 1.3.4 Non-gel Matrix Capillary Electrophoresis
• 1.4 Classification of Capillary Sequencing by Array Size
  • 1.4.1 Overview: Global Capillary Sequencing Market Size by Array Size: 2021 Versus 2025 Versus 2032
  • 1.4.2 Global Capillary Sequencing Consumption Value Market Share by Array Size in 2025
  • 1.4.3 Single Capillary
  • 1.4.4 8 Capillaries
  • 1.4.5 96/384 Capillaries
• 1.5 Classification of Capillary Sequencing by Effective Sequencing Range
  • 1.5.1 Overview: Global Capillary Sequencing Market Size by Effective Sequencing Range: 2021 Versus 2025 Versus 2032
  • 1.5.2 Global Capillary Sequencing Consumption Value Market Share by Effective Sequencing Range in 2025
  • 1.5.3 < 700 bp
  • 1.5.4 700–1000 bp
  • 1.5.5 > 1000 bp
• 1.6 Global Capillary Sequencing Market by Application
  • 1.6.1 Overview: Global Capillary Sequencing Market Size by Application: 2021 Versus 2025 Versus 2032
  • 1.6.2 Clinical Medicine
  • 1.6.3 Gene Therapy
  • 1.6.4 Forensic Identification
  • 1.6.5 Other
• 1.7 Global Capillary Sequencing Market Size & Forecast
• 1.8 Global Capillary Sequencing Market Size and Forecast by Region
  • 1.8.1 Global Capillary Sequencing Market Size by Region: 2021 VS 2025 VS 2032
  • 1.8.2 Global Capillary Sequencing Market Size by Region, (2021-2032)
  • 1.8.3 North America Capillary Sequencing Market Size and Prospect (2021-2032)
  • 1.8.4 Europe Capillary Sequencing Market Size and Prospect (2021-2032)
  • 1.8.5 Asia-Pacific Capillary Sequencing Market Size and Prospect (2021-2032)
  • 1.8.6 South America Capillary Sequencing Market Size and Prospect (2021-2032)
  • 1.8.7 Middle East & Africa Capillary Sequencing Market Size and Prospect (2021-2032)

2 Company Profiles

• 2.1 Thermo Fisher Scientific Inc.
  • 2.1.1 Thermo Fisher Scientific Inc. Details
  • 2.1.2 Thermo Fisher Scientific Inc. Major Business
  • 2.1.3 Thermo Fisher Scientific Inc. Capillary Sequencing Product and Solutions
  • 2.1.4 Thermo Fisher Scientific Inc. Capillary Sequencing Revenue, Gross Margin and Market Share (2021-2026)
  • 2.1.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
• 2.2 Promega Corporation
  • 2.2.1 Promega Corporation Details
  • 2.2.2 Promega Corporation Major Business
  • 2.2.3 Promega Corporation Capillary Sequencing Product and Solutions
  • 2.2.4 Promega Corporation Capillary Sequencing Revenue, Gross Margin and Market Share (2021-2026)
  • 2.2.5 Promega Corporation Recent Developments and Future Plans
• 2.3 Hitachi High-Tech Corporation
  • 2.3.1 Hitachi High-Tech Corporation Details
  • 2.3.2 Hitachi High-Tech Corporation Major Business
  • 2.3.3 Hitachi High-Tech Corporation Capillary Sequencing Product and Solutions
  • 2.3.4 Hitachi High-Tech Corporation Capillary Sequencing Revenue, Gross Margin and Market Share (2021-2026)
  • 2.3.5 Hitachi High-Tech Corporation Recent Developments and Future Plans
• 2.4 Azenta
  • 2.4.1 Azenta Details
  • 2.4.2 Azenta Major Business
  • 2.4.3 Azenta Capillary Sequencing Product and Solutions
  • 2.4.4 Azenta Capillary Sequencing Revenue, Gross Margin and Market Share (2021-2026)
  • 2.4.5 Azenta Recent Developments and Future Plans
• 2.5 Eurofins Scientific
  • 2.5.1 Eurofins Scientific Details
  • 2.5.2 Eurofins Scientific Major Business
  • 2.5.3 Eurofins Scientific Capillary Sequencing Product and Solutions
  • 2.5.4 Eurofins Scientific Capillary Sequencing Revenue, Gross Margin and Market Share (2021-2026)
  • 2.5.5 Eurofins Scientific Recent Developments and Future Plans
• 2.6 Macrogen, Inc.
  • 2.6.1 Macrogen, Inc. Details
  • 2.6.2 Macrogen, Inc. Major Business
  • 2.6.3 Macrogen, Inc. Capillary Sequencing Product and Solutions
  • 2.6.4 Macrogen, Inc. Capillary Sequencing Revenue, Gross Margin and Market Share (2021-2026)
  • 2.6.5 Macrogen, Inc. Recent Developments and Future Plans
• 2.7 GenScript Biotech Corporation
  • 2.7.1 GenScript Biotech Corporation Details
  • 2.7.2 GenScript Biotech Corporation Major Business
  • 2.7.3 GenScript Biotech Corporation Capillary Sequencing Product and Solutions
  • 2.7.4 GenScript Biotech Corporation Capillary Sequencing Revenue, Gross Margin and Market Share (2021-2026)
  • 2.7.5 GenScript Biotech Corporation Recent Developments and Future Plans
• 2.8 Sangon Biotech Co., Ltd.
  • 2.8.1 Sangon Biotech Co., Ltd. Details
  • 2.8.2 Sangon Biotech Co., Ltd. Major Business
  • 2.8.3 Sangon Biotech Co., Ltd. Capillary Sequencing Product and Solutions
  • 2.8.4 Sangon Biotech Co., Ltd. Capillary Sequencing Revenue, Gross Margin and Market Share (2021-2026)
  • 2.8.5 Sangon Biotech Co., Ltd. Recent Developments and Future Plans
• 2.9 Beijing Tsingke Biotech
  • 2.9.1 Beijing Tsingke Biotech Details
  • 2.9.2 Beijing Tsingke Biotech Major Business
  • 2.9.3 Beijing Tsingke Biotech Capillary Sequencing Product and Solutions
  • 2.9.4 Beijing Tsingke Biotech Capillary Sequencing Revenue, Gross Margin and Market Share (2021-2026)
  • 2.9.5 Beijing Tsingke Biotech Recent Developments and Future Plans
• 2.10 GENEWIZ
  • 2.10.1 GENEWIZ Details
  • 2.10.2 GENEWIZ Major Business
  • 2.10.3 GENEWIZ Capillary Sequencing Product and Solutions
  • 2.10.4 GENEWIZ Capillary Sequencing Revenue, Gross Margin and Market Share (2021-2026)
  • 2.10.5 GENEWIZ Recent Developments and Future Plans
• 2.11 Source BioScience Limited
  • 2.11.1 Source BioScience Limited Details
  • 2.11.2 Source BioScience Limited Major Business
  • 2.11.3 Source BioScience Limited Capillary Sequencing Product and Solutions
  • 2.11.4 Source BioScience Limited Capillary Sequencing Revenue, Gross Margin and Market Share (2021-2026)
  • 2.11.5 Source BioScience Limited Recent Developments and Future Plans
• 2.12 Microsynth AG
  • 2.12.1 Microsynth AG Details
  • 2.12.2 Microsynth AG Major Business
  • 2.12.3 Microsynth AG Capillary Sequencing Product and Solutions
  • 2.12.4 Microsynth AG Capillary Sequencing Revenue, Gross Margin and Market Share (2021-2026)
  • 2.12.5 Microsynth AG Recent Developments and Future Plans
• 2.13 BaseClear B.V.
  • 2.13.1 BaseClear B.V. Details
  • 2.13.2 BaseClear B.V. Major Business
  • 2.13.3 BaseClear B.V. Capillary Sequencing Product and Solutions
  • 2.13.4 BaseClear B.V. Capillary Sequencing Revenue, Gross Margin and Market Share (2021-2026)
  • 2.13.5 BaseClear B.V. Recent Developments and Future Plans
• 2.14 MCLAB
  • 2.14.1 MCLAB Details
  • 2.14.2 MCLAB Major Business
  • 2.14.3 MCLAB Capillary Sequencing Product and Solutions
  • 2.14.4 MCLAB Capillary Sequencing Revenue, Gross Margin and Market Share (2021-2026)
  • 2.14.5 MCLAB Recent Developments and Future Plans
• 2.15 Quintara Biosciences
  • 2.15.1 Quintara Biosciences Details
  • 2.15.2 Quintara Biosciences Major Business
  • 2.15.3 Quintara Biosciences Capillary Sequencing Product and Solutions
  • 2.15.4 Quintara Biosciences Capillary Sequencing Revenue, Gross Margin and Market Share (2021-2026)
  • 2.15.5 Quintara Biosciences Recent Developments and Future Plans
• 2.16 Eton Bioscience Inc.
  • 2.16.1 Eton Bioscience Inc. Details
  • 2.16.2 Eton Bioscience Inc. Major Business
  • 2.16.3 Eton Bioscience Inc. Capillary Sequencing Product and Solutions
  • 2.16.4 Eton Bioscience Inc. Capillary Sequencing Revenue, Gross Margin and Market Share (2021-2026)
  • 2.16.5 Eton Bioscience Inc. Recent Developments and Future Plans
• 2.17 NimaGen B.V.
  • 2.17.1 NimaGen B.V. Details
  • 2.17.2 NimaGen B.V. Major Business
  • 2.17.3 NimaGen B.V. Capillary Sequencing Product and Solutions
  • 2.17.4 NimaGen B.V. Capillary Sequencing Revenue, Gross Margin and Market Share (2021-2026)
  • 2.17.5 NimaGen B.V. Recent Developments and Future Plans
• 2.18 FASMAC Co., Ltd.
  • 2.18.1 FASMAC Co., Ltd. Details
  • 2.18.2 FASMAC Co., Ltd. Major Business
  • 2.18.3 FASMAC Co., Ltd. Capillary Sequencing Product and Solutions
  • 2.18.4 FASMAC Co., Ltd. Capillary Sequencing Revenue, Gross Margin and Market Share (2021-2026)
  • 2.18.5 FASMAC Co., Ltd. Recent Developments and Future Plans
• 2.19 ACGT, Inc.
  • 2.19.1 ACGT, Inc. Details
  • 2.19.2 ACGT, Inc. Major Business
  • 2.19.3 ACGT, Inc. Capillary Sequencing Product and Solutions
  • 2.19.4 ACGT, Inc. Capillary Sequencing Revenue, Gross Margin and Market Share (2021-2026)
  • 2.19.5 ACGT, Inc. Recent Developments and Future Plans

3 Market Competition, by Players

• 3.1 Global Capillary Sequencing Revenue and Share by Players (2021-2026)
• 3.2 Market Share Analysis (2025)
  • 3.2.1 Market Share of Capillary Sequencing by Company Revenue
  • 3.2.2 Top 3 Capillary Sequencing Players Market Share in 2025
  • 3.2.3 Top 6 Capillary Sequencing Players Market Share in 2025
• 3.3 Capillary Sequencing Market: Overall Company Footprint Analysis
  • 3.3.1 Capillary Sequencing Market: Region Footprint
  • 3.3.2 Capillary Sequencing Market: Company Product Type Footprint
  • 3.3.3 Capillary Sequencing Market: Company Product Application Footprint
• 3.4 New Market Entrants and Barriers to Market Entry
• 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

• 4.1 Global Capillary Sequencing Consumption Value and Market Share by Type (2021-2026)
• 4.2 Global Capillary Sequencing Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

• 5.1 Global Capillary Sequencing Consumption Value Market Share by Application (2021-2026)
• 5.2 Global Capillary Sequencing Market Forecast by Application (2027-2032)

6 North America

• 6.1 North America Capillary Sequencing Consumption Value by Type (2021-2032)
• 6.2 North America Capillary Sequencing Market Size by Application (2021-2032)
• 6.3 North America Capillary Sequencing Market Size by Country
  • 6.3.1 North America Capillary Sequencing Consumption Value by Country (2021-2032)
  • 6.3.2 United States Capillary Sequencing Market Size and Forecast (2021-2032)
  • 6.3.3 Canada Capillary Sequencing Market Size and Forecast (2021-2032)
  • 6.3.4 Mexico Capillary Sequencing Market Size and Forecast (2021-2032)

7 Europe

• 7.1 Europe Capillary Sequencing Consumption Value by Type (2021-2032)
• 7.2 Europe Capillary Sequencing Consumption Value by Application (2021-2032)
• 7.3 Europe Capillary Sequencing Market Size by Country
  • 7.3.1 Europe Capillary Sequencing Consumption Value by Country (2021-2032)
  • 7.3.2 Germany Capillary Sequencing Market Size and Forecast (2021-2032)
  • 7.3.3 France Capillary Sequencing Market Size and Forecast (2021-2032)
  • 7.3.4 United Kingdom Capillary Sequencing Market Size and Forecast (2021-2032)
  • 7.3.5 Russia Capillary Sequencing Market Size and Forecast (2021-2032)
  • 7.3.6 Italy Capillary Sequencing Market Size and Forecast (2021-2032)

8 Asia-Pacific

• 8.1 Asia-Pacific Capillary Sequencing Consumption Value by Type (2021-2032)
• 8.2 Asia-Pacific Capillary Sequencing Consumption Value by Application (2021-2032)
• 8.3 Asia-Pacific Capillary Sequencing Market Size by Region
  • 8.3.1 Asia-Pacific Capillary Sequencing Consumption Value by Region (2021-2032)
  • 8.3.2 China Capillary Sequencing Market Size and Forecast (2021-2032)
  • 8.3.3 Japan Capillary Sequencing Market Size and Forecast (2021-2032)
  • 8.3.4 South Korea Capillary Sequencing Market Size and Forecast (2021-2032)
  • 8.3.5 India Capillary Sequencing Market Size and Forecast (2021-2032)
  • 8.3.6 Southeast Asia Capillary Sequencing Market Size and Forecast (2021-2032)
  • 8.3.7 Australia Capillary Sequencing Market Size and Forecast (2021-2032)

9 South America

• 9.1 South America Capillary Sequencing Consumption Value by Type (2021-2032)
• 9.2 South America Capillary Sequencing Consumption Value by Application (2021-2032)
• 9.3 South America Capillary Sequencing Market Size by Country
  • 9.3.1 South America Capillary Sequencing Consumption Value by Country (2021-2032)
  • 9.3.2 Brazil Capillary Sequencing Market Size and Forecast (2021-2032)
  • 9.3.3 Argentina Capillary Sequencing Market Size and Forecast (2021-2032)

10 Middle East & Africa

• 10.1 Middle East & Africa Capillary Sequencing Consumption Value by Type (2021-2032)
• 10.2 Middle East & Africa Capillary Sequencing Consumption Value by Application (2021-2032)
• 10.3 Middle East & Africa Capillary Sequencing Market Size by Country
  • 10.3.1 Middle East & Africa Capillary Sequencing Consumption Value by Country (2021-2032)
  • 10.3.2 Turkey Capillary Sequencing Market Size and Forecast (2021-2032)
  • 10.3.3 Saudi Arabia Capillary Sequencing Market Size and Forecast (2021-2032)
  • 10.3.4 UAE Capillary Sequencing Market Size and Forecast (2021-2032)

11 Market Dynamics

• 11.1 Capillary Sequencing Market Drivers
• 11.2 Capillary Sequencing Market Restraints
• 11.3 Capillary Sequencing Trends Analysis
• 11.4 Porters Five Forces Analysis
  • 11.4.1 Threat of New Entrants
  • 11.4.2 Bargaining Power of Suppliers
  • 11.4.3 Bargaining Power of Buyers
  • 11.4.4 Threat of Substitutes
  • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

• 12.1 Capillary Sequencing Industry Chain
• 12.2 Capillary Sequencing Upstream Analysis
• 12.3 Capillary Sequencing Midstream Analysis
• 12.4 Capillary Sequencing Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Research Process and Data Source

According to our (Global Info Research) latest study, the global Capillary Sequencing market size was valued at US$ 630 million in 2025 and is forecast to a readjusted size of US$ 870 million by 2032 with a CAGR of 4.7% during review period.
Capillary sequencing is a DNA sequence reading method based on the dideoxy chain termination method as its core chemical principle, and fluorescently labeled terminators and capillary electrophoresis separation and detection as key technical pathways. Capillary sequencing focuses on instrument systems, sequencing reaction reagents, capillary arrays and polymer consumables, base recognition and peak analysis software, and commercial Sanger sequencing service platforms with in-house laboratory capabilities for small-scale, targeted, confirmatory DNA sequence analysis.
From a demand structure perspective, the growth momentum of Sanger sequencing mainly comes from existing essential needs rather than emerging explosive growth. Plasmid validation and PCR product sequencing remain fundamental requirements in academic research. Pharmaceutical and synthetic biology companies continue to rely on Sanger as a low-cost, highly reliable validation tool for plasmid, vector, edited site, construct, and key sequence confirmation. Clinical laboratories retain Sanger workflows for some single-gene testing, validation of known family variants, and confirmation of NGS positive results. Overall, the unit price of routine reads remains under pressure, but high-complexity templates, compliant services, and rapid localized delivery will maintain a certain profit margin.
This report is a detailed and comprehensive analysis for global Capillary Sequencing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Capillary Sequencing market size and forecasts, in consumption value ($ Million), 2021-2032
Global Capillary Sequencing market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Capillary Sequencing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Capillary Sequencing market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Capillary Sequencing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Capillary Sequencing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Promega Corporation, Hitachi High-Tech Corporation, Azenta, Eurofins Scientific, Macrogen, Inc., GenScript Biotech Corporation, Sangon Biotech Co., Ltd., Beijing Tsingke Biotech, GENEWIZ, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Capillary Sequencing market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Capillary Gel Electrophoresis (CGE)
Non-gel Matrix Capillary Electrophoresis
Market segment by Array Size
Single Capillary
8 Capillaries
96/384 Capillaries
Market segment by Effective Sequencing Range
< 700 bp
700–1000 bp
> 1000 bp
Market segment by Application
Clinical Medicine
Gene Therapy
Forensic Identification
Other
Market segment by players, this report covers
Thermo Fisher Scientific Inc.
Promega Corporation
Hitachi High-Tech Corporation
Azenta
Eurofins Scientific
Macrogen, Inc.
GenScript Biotech Corporation
Sangon Biotech Co., Ltd.
Beijing Tsingke Biotech
GENEWIZ
Source BioScience Limited
Microsynth AG
BaseClear B.V.
MCLAB
Quintara Biosciences
Eton Bioscience Inc.
NimaGen B.V.
FASMAC Co., Ltd.
ACGT, Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Capillary Sequencing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Capillary Sequencing, with revenue, gross margin, and global market share of Capillary Sequencing from 2021 to 2026.
Chapter 3, the Capillary Sequencing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Capillary Sequencing market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Capillary Sequencing.
Chapter 13, to describe Capillary Sequencing research findings and conclusion.